MONTVALE, N.J. — After five years of research and testing, Bayer ES’ Maxforce Tick Management System (TMS) – a new product developed to control ticks and reduce the risk of Lyme disease and other tick-borne infections – has received federal registration and is now available in key states affected by Lyme disease.
Bayer ES is offering interested PMPs the opportunity to learn more about the latest developments in the pressing public health issue of tick control with specialized meetings in key regional locations across the Eastern seaboard (see calendar of meetings below).
The three-hour sessions provide PMPs with the tools to address this growing trend in pest control, including information on tick and tick-borne disease biology, prevention and protection techniques, as well as revolutionary control methods. Participants have access to exclusive marketing and training modules to communicate this integrated tick control method to employees and customers. Attendees will also have opportunity to become certified applicators of the Maxforce Tick Management System.
Available now to homeowners through licensed applicators, the Maxforce Tick Management System attacks the root of the Lyme disease problem by treating the primary hosts of the disease – the field mouse and chipmunk. In field trials, researchers from the Centers for Disease Control and Prevention (CDC) and the Maxforce Tick Management System tested the product on many residential properties in Connecticut. The results showed nearly an 80% reduction in the nymphal tick populations after the first year and a 96% reduction over two years.
“Contrary to popular belief, small rodents, not deer, are responsible for transmitting the Lyme disease bacteria to ticks,” said Chuck Cole, product manger for the Maxforce Tick Management System. “By treating the rodents in residential properties, we get to the root of the problem and break the cycle of Lyme disease. The Maxforce Tick Management System kills ticks during the critical larval and nymphal stages when they are contracting the Lyme bacteria and other tick-borne infections from small rodents,” Cole said.
According to the CDC, greater than 23,000 human cases of Lyme disease were recorded in 2002, with an estimated 9 out of 10 cases going unreported. Once infected with Lyme disease, a person may experience flu-like symptoms and develop a red rash in the shape of a bull’s eye. Because the symptoms of Lyme disease so closely mimic the flu, it often goes undiagnosed and can lead to more serious health problems if left untreated.
To find out more about the meetings or Maxforce TMS, PMPs can contact their local representative, visit www.bayerprocentral.com, or call 1-800/331-2867 for more information.
EVENT DATES AND TIMES:
Monday, Jan. 12, 2004 (register by Jan. 8)
Tuesday, Jan. 13, 2004 (register by Jan. 9)
Tuesday, Feb. 3, 2004 (register by Jan. 30)
Wednesday, Feb. 4, 2004 (register by February 2)